Zealand interim report for the first nine months of 2015 (un-audited): Financial results on target with significant pipeline ...
Lyxumia(r) royalties and milestone revenue of DKK 20.6 million / EUR 2.7 million Net operating expenses of DKK 176.2 million / EUR 23.6 million for the period Net result of DKK -183.7 million / EUR -24.6 million Financial guidance for 2015 unchanged …